150 related articles for article (PubMed ID: 18242988)
1. Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3.
Hayes ME; Wallace GA; Grongsaard P; Bischoff A; George DM; Miao W; McPherson MJ; Stoffel RH; Green DW; Roth GP
Bioorg Med Chem Lett; 2008 Mar; 18(5):1573-6. PubMed ID: 18242988
[TBL] [Abstract][Full Text] [Related]
2. Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: discovery, characterization and preliminary SAR of a promising lead.
Thoma G; Baenteli R; Lewis I; Wagner T; Oberer L; Blum W; Glickman F; Streiff MB; Zerwes HG
Bioorg Med Chem Lett; 2009 Nov; 19(21):6185-8. PubMed ID: 19783143
[TBL] [Abstract][Full Text] [Related]
3. Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3.
Hayes ME; Breinlinger EC; Wallace GA; Grongsaard P; Miao W; McPherson MJ; Stoffel RH; Green DW; Roth GP
Bioorg Med Chem Lett; 2008 Apr; 18(7):2414-9. PubMed ID: 18337097
[TBL] [Abstract][Full Text] [Related]
4. Towards small-molecule CXCR3 ligands with clinical potential.
Wijtmans M; Verzijl D; Leurs R; de Esch IJ; Smit MJ
ChemMedChem; 2008 Jun; 3(6):861-72. PubMed ID: 18442035
[TBL] [Abstract][Full Text] [Related]
5. Novel CXCR3 antagonists with a piperazinyl-piperidine core.
McGuinness BF; Carroll CD; Zawacki LG; Dong G; Yang C; Hobbs DW; Jacob-Samuel B; Hall JW; Jenh CH; Kozlowski JA; Anilkumar GN; Rosenblum SB
Bioorg Med Chem Lett; 2009 Sep; 19(17):5205-8. PubMed ID: 19647429
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of 3H-quinazolin-4-ones and 3H-pyrido[2,3-d]pyrimidin-4-ones as CXCR3 receptor antagonists.
Storelli S; Verzijl D; Al-Badie J; Elders N; Bosch L; Timmerman H; Smit MJ; De Esch IJ; Leurs R
Arch Pharm (Weinheim); 2007 Jun; 340(6):281-91. PubMed ID: 17562560
[TBL] [Abstract][Full Text] [Related]
7. Benzimidazole-substituted (3-phenoxypropyl)amines as histamine H3 receptor ligands.
Aslanian R; Zhu X; Vaccaro HA; Shih NY; Piwinski JJ; Williams SM; West RE
Bioorg Med Chem Lett; 2008 Sep; 18(18):5032-6. PubMed ID: 18752952
[TBL] [Abstract][Full Text] [Related]
8. III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl-piperazinyl-piperidine scaffold.
Kim SH; Anilkumar GN; Zawacki LG; Zeng Q; Yang DY; Shao Y; Dong G; Xu X; Yu W; Jiang Y; Jenh CH; Hall JW; Carroll CD; Hobbs DW; Baldwin JJ; McGuinness BF; Rosenblum SB; Kozlowski JA; Shankar BB; Shih NY
Bioorg Med Chem Lett; 2011 Dec; 21(23):6982-6. PubMed ID: 22018463
[TBL] [Abstract][Full Text] [Related]
9. Discovery and structure-activity relationship of the first non-peptide competitive human glucagon receptor antagonists.
Madsen P; Knudsen LB; Wiberg FC; Carr RD
J Med Chem; 1998 Dec; 41(26):5150-7. PubMed ID: 9857085
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationship of imidazo[1,2-a]benzimidazoles as corticotropin-releasing factor 1 receptor antagonists.
Han X; Pin SS; Burris K; Fung LK; Huang S; Taber MT; Zhang J; Dubowchik GM
Bioorg Med Chem Lett; 2005 Sep; 15(18):4029-32. PubMed ID: 15982881
[TBL] [Abstract][Full Text] [Related]
11. Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives.
Ogino Y; Ohtake N; Nagae Y; Matsuda K; Moriya M; Suga T; Ishikawa M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
Bioorg Med Chem Lett; 2008 Sep; 18(18):5010-4. PubMed ID: 18723347
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors.
Hasegawa M; Nishigaki N; Washio Y; Kano K; Harris PA; Sato H; Mori I; West RI; Shibahara M; Toyoda H; Wang L; Nolte RT; Veal JM; Cheung M
J Med Chem; 2007 Sep; 50(18):4453-70. PubMed ID: 17676829
[TBL] [Abstract][Full Text] [Related]
13. CXCR3 antagonists: quaternary ammonium salts equipped with biphenyl- and polycycloaliphatic-anchors.
Wijtmans M; Verzijl D; Bergmans S; Lai M; Bosch L; Smit MJ; de Esch IJ; Leurs R
Bioorg Med Chem; 2011 Jun; 19(11):3384-93. PubMed ID: 21570852
[TBL] [Abstract][Full Text] [Related]
14. New benzimidazoles as thrombopoietin receptor agonists.
Safonov IG; Heerding DA; Keenan RM; Price AT; Erickson-Miller CL; Hopson CB; Levin JL; Lord KA; Tapley PM
Bioorg Med Chem Lett; 2006 Mar; 16(5):1212-6. PubMed ID: 16376078
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists.
Ogino Y; Ohtake N; Nagae Y; Matsuda K; Ishikawa M; Moriya M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
Bioorg Med Chem Lett; 2008 Sep; 18(18):4997-5001. PubMed ID: 18752943
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and SAR of potent and selective androgen receptor antagonists: 5,6-Dichloro-benzimidazole derivatives.
Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Feb; 17(3):784-8. PubMed ID: 17095226
[TBL] [Abstract][Full Text] [Related]
17. II. SAR studies of pyridyl-piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists.
Shao Y; Anilkumar GN; Carroll CD; Dong G; Hall JW; Hobbs DW; Jiang Y; Jenh CH; Kim SH; Kozlowski JA; McGuinness BF; Rosenblum SB; Schulman I; Shih NY; Shu Y; Wong MK; Yu W; Zawacki LG; Zeng Q
Bioorg Med Chem Lett; 2011 Mar; 21(5):1527-31. PubMed ID: 21277198
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.
Bongartz JP; Buntinx M; Coesemans E; Hermans B; Lommen GV; Wauwe JV
Bioorg Med Chem Lett; 2008 Nov; 18(21):5819-23. PubMed ID: 18922694
[TBL] [Abstract][Full Text] [Related]
19. Design and optimization of imidazole derivatives as potent CXCR3 antagonists.
Du X; Chen X; Mihalic JT; Deignan J; Duquette J; Li AR; Lemon B; Ma J; Miao S; Ebsworth K; Sullivan TJ; Tonn G; Collins TL; Medina JC
Bioorg Med Chem Lett; 2008 Jan; 18(2):608-13. PubMed ID: 18063364
[TBL] [Abstract][Full Text] [Related]
20. Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists.
Li AR; Johnson MG; Liu J; Chen X; Du X; Mihalic JT; Deignan J; Gustin DJ; Duquette J; Fu Z; Zhu L; Marcus AP; Bergeron P; McGee LR; Danao J; Lemon B; Carabeo T; Sullivan T; Ma J; Tang L; Tonn G; Collins TL; Medina JC
Bioorg Med Chem Lett; 2008 Jan; 18(2):688-93. PubMed ID: 18061451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
